Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Thicker hair isn't always stronger.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Albizia saponaria stem bark shows promise as a natural antidandruff treatment.

The treatment using a special hydrogel shows promise for promoting hair growth.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Inflammation damages sweat ducts, causing sweat gland injury.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Early regulatory T cells are crucial for normal skin pigmentation.

Erianin may effectively treat alopecia areata by targeting the immune system.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Laser hair removal shows promising short-term results but isn't yet permanent.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The new skin model can predict how chemicals might cause skin allergies.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Trichoscopy can help identify systemic diseases, not just hair and scalp issues.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.